InvestorsHub Logo
Post# of 252190
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: genisi post# 142805

Thursday, 05/31/2012 1:37:33 PM

Thursday, May 31, 2012 1:37:33 PM

Post# of 252190
I found the data from phase II of the two BRAF inhibitors and with the caveat of comparing results from different trials, they seem to be in the same ballpark.

BRIM2 phase II data for Zelboraf (vemurafenib)

http://www.asco.org/ascov2/Meetings/Abstracts?&vmview=abst_detail_view&confID=102&abstractID=84075

BRF113710 phase II study of dabrafenib (GSK2118436)

http://www.gsk-clinicalstudyregister.com/result_comp_list.jsp?phase=Phase+2&studyType=All&population=All&marketing=All&compound=dabrafenib

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.